Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol
Year: 2025
Type: article
Language: en
Topic: Tuberculosis Research and Epidemiology
Authors and affiliations:
raw_author_name: Laura Diab Casares
raw_affiliation_strings: Clinical Microbiology Department, Consorcio Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain
Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain
raw_author_name: Juan Espinosa Pereiro
raw_affiliation_strings: Infectious Diseases Department, Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain
Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain
Networked Biomedical Research Center for Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
raw_author_name: María Teresa Tórtola Fernández
raw_affiliation_strings: Microbiology Department, Autonomous University of Barcelona, Medicine Department, Campus Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain
Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain
Networked Biomedical Research Center for Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
raw_author_name: Xavier Casas García
raw_affiliation_strings: Respiratory Department, Serveis Clinics SAU, Barcelona, Cataluña, Spain
Respiratory Infections Working Group of the Catalan Society of Respiratory Medicine (SOCAP), Cataluña, Cataluña
raw_author_name: Joan Pau Millet
raw_affiliation_strings: CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain
Epidemiology, Public Health Agency of Catalonia, Barcelona, Cataluña, Spain
raw_author_name: Virginia Pomar Solchaga
raw_affiliation_strings: Infectious Diseases Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Cataluña, Spain
raw_author_name: Enrique Navas Elorza
raw_affiliation_strings: Infectious Diseases Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
raw_author_name: Jesús Troya García
raw_affiliation_strings: Department of Internal Medicine, Hospital Universitario Infanta Leonor, Madrid, Spain
raw_author_name: Alberto Díaz de Santiago
raw_affiliation_strings: Department of Internal Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
raw_author_name: Rafael Luque Márquez
raw_affiliation_strings: Infectious Diseases Department, Hospital Universitario Virgen del Rocío, Sevilla, Andalucía, Spain
raw_author_name: Juan Francisco Medina Gallardo
raw_affiliation_strings: Integrated Research Program on Tuberculosis and Nontuberculous Mycobacteria (PII-TB&MNT), Spanish Society of Respiratory Medicine and Thoracic Surgery (SEPAR), Spain
Medical–Surgical Unit for Respiratory Diseases (UMQER), Hospital Universitario Virgen del Rocío, Sevilla, Andalucía, Spain
raw_author_name: Verónica González Galán
raw_affiliation_strings: Clinical Unit of Infectious Diseases, Microbiology and Clinical Parasitology (UCEIMP), Hospital Universitario Virgen del Rocío, Sevilla, Spain
Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain
Seville Institute of Biomedicine, Sevilla, Andalucía, Spain
raw_author_name: Marta Montero Alonso
raw_affiliation_strings: Infectious Diseases Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain
raw_author_name: Ana Gil Brusola
raw_affiliation_strings: Microbiology Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain
raw_author_name: Ramón Rabuñal Rey
raw_affiliation_strings: Department of Internal Medicine, Hospital Universitario Lucus Augusti, Lugo, Spain
Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain
raw_author_name: Luis Anibarro García
raw_affiliation_strings: Immunology Research Group, Research Institute, Sanitaria Galicia Sur, Santiago de Compostela, Spain
Tuberculosis Unit, Infectious Diseases, Internal Medicine Department, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Galicia, Spain
raw_author_name: Francisco Sanz Herrero
raw_affiliation_strings: Respiratory Department, Consorcio Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain
raw_author_name: Remedio Guna Serrano
raw_affiliation_strings: Clinical Microbiology Department, Consorcio Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain
Clinical Microbiology Department, Faculty of Medicine, University of Valencia, Valencia, Spain
Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain
raw_author_name: Montserrat Garrigó Fullola
raw_affiliation_strings: Clinical Microbiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Department of Genetics and Microbiology, Autonomous University of Barcelona, Barcelona, Cataluña, Spain
Sant Pau Biomedical Research Institute, Barcelona, Cataluña, Spain
raw_author_name: Marta Tato Díez
raw_affiliation_strings: Clinical Microbiology Department, Hospital Universitario Ramon y Cajal, Madrid, Madrid, Spain
raw_author_name: Tamar Talavan Zanón
raw_affiliation_strings: Clinical Microbiology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
raw_author_name: Maria Francisca Portero
raw_affiliation_strings: Clinical Microbiology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
raw_author_name: Pilar Alonso García
raw_affiliation_strings: Clinical Microbiology Department, Hospital Universitario Lucus Augusti, Lugo, Galicia, Spain
raw_author_name: Ana M Saez López
raw_affiliation_strings: Clinical Microbiology Department, Hospital Provincial de Pontevedra, Pontevedra, Galicia, Spain
raw_author_name: María Luisa Aznar
raw_affiliation_strings: Infectious Diseases Department, Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain
Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain
Networked Biomedical Research Center for Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
raw_author_name: Joan Martínez Campreciós
raw_affiliation_strings: Infectious Diseases Department, Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain
Networked Biomedical Research Center for Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
raw_author_name: Núria Saborit
raw_affiliation_strings: Infectious Diseases Department, Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain
raw_author_name: Adrián Sánchez Montalvá
raw_affiliation_strings: Infectious Diseases Department, Hospital Universitario Vall d'Hebron, Barcelona, Cataluña, Spain
Mycobacteria Study Group, Spanish Society of Infectious Diseases and Clinical Microbiology (GEIM-SEIMC), Spain, Spain
Networked Biomedical Research Center for Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain